Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
32
33
Next >
Biogen’s Aduhelm Crashes the Biotech Sector
April 13, 2022
Tickers
BIIB
NVS
VTRS
Tags
Market News
NASDAQ:BIIB,NASDAQ:VTRS,NYSE:NVS,
NVS
From
InvestorPlace
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
April 08, 2022
Tickers
AZN
BIIB
ENTX
GLSI
Tags
Market Insight, Financial Articles
XBI
GME
From
InvestorPlace
Why Is Trevi Therapeutics (TRVI) Stock On the Move Today?
April 08, 2022
Tickers
BIIB
CRWD
EDU
TRVI
Tags
EDU
Today's Market
BIIB
From
InvestorPlace
Why Is Biogen (BIIB) Stock in the Spotlight Today?
April 08, 2022
Tickers
BIIB
LLY
Tags
NASDAQ:BIIB,NYSE:LLY
LLY
BIIB
From
InvestorPlace
Morning Brief: Top Stories Dominating Financial Media on Friday, April 8
April 08, 2022
Tickers
AMZN
BA
BIIB
BRK-A
Tags
$ETH
BA
NIO
From
Benzinga
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
April 08, 2022
Tickers
BIIB
BLUE
GILD
IBB
Tags
NVS
MRNA
BIIB
From
InvestorPlace
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
Tags
Aduhelm
General
Government
From
Benzinga
3 Healthcare Stocks That Could Help Set You Up for Life
April 07, 2022
Tickers
BIIB
GMED
LLY
SGEN
Tags
Market News
SGEN
LLY
From
Motley Fool
Could Amylyx Pharmaceuticals Have a Blockbuster ALS Treatment?
March 29, 2022
Tickers
AMLX
BIIB
Tags
AMLX
Market News
BIIB
From
Motley Fool
Ionis-Biogen Partnered Amyotrophic Lateral Sclerosis Trial Disappoints
March 28, 2022
Tickers
BIIB
IONS
Tags
Movers
News
Briefs
From
Benzinga
Is Johnson & Johnson Setting a Dangerous Precedent for the Healthcare Industry?
March 26, 2022
Tickers
BIIB
JNJ
MRNA
OCGN
Tags
Recent Press Releases
BIIB
MRNA
From
Motley Fool
Why I Sold Kohl’s Corporation Despite Possible Buyout Deal
March 22, 2022
Tickers
BIIB
KSS
NLSN
Tags
NYSE:KSS,NYSE:NLSN,NASDAQ:BIIB
Market News
Stocks to Sell
From
InvestorPlace
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Market News
Phase 2 Trial
Benzinga
From
Benzinga
2 Red Flags for Biogen's Future
March 22, 2022
Tickers
BIIB
LLY
Tags
Market News
BIIB
Recent Press Releases
From
Motley Fool
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
Biotech
News
Briefs
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
General
News
Briefs
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
Earnings
SXTC
BBI
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
Briefs
News
Biotech
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
March 08, 2022
Tickers
ACET
ACTD
ALEC
AREN
Tags
PEN
TYRA
BIIB
From
Benzinga
10 Biggest Price Target Changes For Tuesday
March 08, 2022
Tickers
AUPH
AVDX
BBBY
BIIB
Tags
BIIB
WLL
Small Cap
From
Benzinga
As President Biden proposed, Medicare needs the ability to negotiate drug prices
March 07, 2022
Tickers
BIIB
Tags
BIIB
From
MarketWatch
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
March 04, 2022
Tickers
BIIB
CEMI
ESALY
EYEN
Tags
Benzinga
FDA
Penny Stocks
From
Benzinga
Why This Analyst Sees Roughly 20% Upside In This Large-Cap Biopharma
March 03, 2022
Tickers
BIIB
Tags
Upgrades
General
Price Target
From
Benzinga
Expert Ratings For Biogen
March 03, 2022
Tickers
BIIB
Tags
Analyst Ratings
Market News
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
March 03, 2022
Tickers
ALGT
AORT
AVTX
BALY
Tags
BALY
RMNI
LUV
From
Benzinga
10 Biggest Price Target Changes For Thursday
March 03, 2022
Tickers
AEO
AI
BHG
BIIB
Tags
AEO
COP
Analyst Ratings
From
Benzinga
Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver
February 28, 2022
Tickers
BIIB
PFE
VTRS
Tags
VTRS
BIIB
PFE
From
MarketWatch
Medicare’s finances and the saga of the Alzheimer’s drug Aduhelm
February 24, 2022
Tickers
BIIB
Tags
BIIB
From
MarketWatch
What Investors Can Learn From Biogen's Drug Approval That No One Wants
February 23, 2022
Tickers
BIIB
Tags
BIIB
Recent Press Releases
Market News
From
Motley Fool
Could Advocacy Groups' Campaign for Aduhelm Benefit Biogen?
February 19, 2022
Tickers
BIIB
Tags
BIIB
Recent Press Releases
Market News
From
Motley Fool
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.